Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of GBP 47.54 billion. The enterprise value is 65.13 billion.

Market Cap	47.54B
Enterprise Value	65.13B

Important Dates

The next estimated earnings date is Wednesday, April 15, 2026.

Earnings Date	Apr 15, 2026
Ex-Dividend Date	Dec 5, 2025

Share Statistics

Current Share Class	220.70M
Shares Outstanding	n/a
Shares Change (YoY)	-3.56%
Shares Change (QoQ)	-0.85%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	94.02%
Float	220.24M

Valuation Ratios

The trailing PE ratio is 11.30 and the forward PE ratio is 11.16.

PE Ratio	11.30
Forward PE	11.16
PS Ratio	0.32
PB Ratio	1.45
P/TBV Ratio	14.75
P/FCF Ratio	20.16
P/OCF Ratio	14.91
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.43, with an EV/FCF ratio of 27.62.

EV / Earnings	15.48
EV / Sales	0.44
EV / EBITDA	9.43
EV / EBIT	10.44
EV / FCF	27.62

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.74.

Current Ratio	1.54
Quick Ratio	1.41
Debt / Equity	0.74
Debt / EBITDA	3.57
Debt / FCF	10.32
Interest Coverage	5.91

Financial Efficiency

Return on equity (ROE) is 13.25% and return on invested capital (ROIC) is 9.15%.

Return on Equity (ROE)	13.25%
Return on Assets (ROA)	4.35%
Return on Invested Capital (ROIC)	9.15%
Return on Capital Employed (ROCE)	10.31%
Weighted Average Cost of Capital (WACC)	5.74%
Revenue Per Employee	1.53M
Profits Per Employee	43,543
Employee Count	96,615
Asset Turnover	1.67
Inventory Turnover	n/a

Taxes

In the past 12 months, Elevance Health has paid 779.41 million in taxes.

Income Tax	779.41M
Effective Tax Rate	15.63%

Stock Price Statistics

The stock price has decreased by -27.50% in the last 52 weeks. The beta is 0.47, so Elevance Health's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	-27.50%
50-Day Moving Average	344.01
200-Day Moving Average	337.24
Relative Strength Index (RSI)	25.50
Average Volume (20 Days)	1,243

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.58

Income Statement

In the last 12 months, Elevance Health had revenue of GBP 147.95 billion and earned 4.21 billion in profits. Earnings per share was 18.73.

Revenue	147.95B
Gross Profit	37.82B
Operating Income	6.16B
Pretax Income	4.99B
Net Income	4.21B
EBITDA	6.72B
EBIT	6.16B
Earnings Per Share (EPS)	18.73

Full Income Statement

Balance Sheet

The company has 26.83 billion in cash and 24.33 billion in debt, giving a net cash position of -17.28 billion.

Cash & Cash Equivalents	26.83B
Total Debt	24.33B
Net Cash	-17.28B
Net Cash Per Share	n/a
Equity (Book Value)	32.71B
Book Value Per Share	147.72
Working Capital	16.32B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.19 billion and capital expenditures -829.19 million, giving a free cash flow of 2.36 billion.

Operating Cash Flow	3.19B
Capital Expenditures	-829.19M
Free Cash Flow	2.36B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 25.56%, with operating and profit margins of 4.17% and 2.84%.

Gross Margin	25.56%
Operating Margin	4.17%
Pretax Margin	3.37%
Profit Margin	2.84%
EBITDA Margin	4.54%
EBIT Margin	4.17%
FCF Margin	1.59%

Dividends & Yields

This stock pays an annual dividend of 5.14, which amounts to a dividend yield of 1.79%.

Dividend Per Share	5.14
Dividend Yield	1.79%
Dividend Growth (YoY)	1.12%
Years of Dividend Growth	8
Payout Ratio	27.43%
Buyback Yield	3.56%
Shareholder Yield	5.34%
Earnings Yield	8.85%
FCF Yield	4.96%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5